Insider Transactions and Holdings
-
Entity Type
-
Individual
-
Role
-
EVP, Chief TO and Risk Officer
-
Stock Symbol
-
JNJ on NYSE
There are no Buy or Sell transactions made by Kathryn E. Wengel since 3/2/2024
Holdings reported by Kathryn E. Wengel for Johnson & Johnson
| Class |
Num Shares |
Value |
Price $ |
Transaction Date |
Ownership |
Underlying Class |
Underlying Amount |
| Common Stock |
94.3K |
$14.8M |
$156.71 |
Feb 14, 2025 |
Direct |
|
|
| Employee Stock Options (Right to Buy) |
30.8K |
$3.09M |
$100.06 |
Feb 15, 2025 |
Direct |
Common Stock |
|
| Restricted Share Units |
1.9K |
$297K |
$156.15 |
Feb 15, 2025 |
Direct |
Common Stock |
|
| Restricted Share Units |
1.82K |
$287K |
$157.85 |
Feb 15, 2024 |
Direct |
Common Stock |
|
| Common Stock |
281 |
$43.9K |
$156.15 |
Feb 13, 2025 |
By ESOP |
|
|
| Common Stock |
75 |
$11.7K |
$156.15 |
Feb 13, 2025 |
By 401k |
|
|
| Performance Share Units |
0 |
$0 |
$156.15 |
Feb 14, 2025 |
Direct |
Common Stock |
|
Transactions reported by Kathryn E. Wengel for Johnson & Johnson
| Sym |
Class |
Transaction |
% |
Value $ |
* Price $ |
Shares |
Shares After |
Date |
Ownership |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.